173 related articles for article (PubMed ID: 22056560)
1. Osterix is regulated by Erk1/2 during osteoblast differentiation.
Choi YH; Gu YM; Oh JW; Lee KY
Biochem Biophys Res Commun; 2011 Nov; 415(3):472-8. PubMed ID: 22056560
[TBL] [Abstract][Full Text] [Related]
2. Akt phosphorylates and regulates the osteogenic activity of Osterix.
Choi YH; Jeong HM; Jin YH; Li H; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2011 Aug; 411(3):637-41. PubMed ID: 21777568
[TBL] [Abstract][Full Text] [Related]
3. Calmodulin-dependent kinase II regulates osteoblast differentiation through regulation of Osterix.
Choi YH; Choi JH; Oh JW; Lee KY
Biochem Biophys Res Commun; 2013 Mar; 432(2):248-55. PubMed ID: 23402759
[TBL] [Abstract][Full Text] [Related]
4. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype.
Zhao M; Xiao G; Berry JE; Franceschi RT; Reddi A; Somerman MJ
J Bone Miner Res; 2002 Aug; 17(8):1441-51. PubMed ID: 12162498
[TBL] [Abstract][Full Text] [Related]
6. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
[TBL] [Abstract][Full Text] [Related]
7. Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix.
Okamura H; Yoshida K; Ochiai K; Haneji T
Bone; 2011 Sep; 49(3):368-75. PubMed ID: 21683816
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase A regulates the osteogenic activity of Osterix.
He S; Choi YH; Choi JK; Yeo CY; Chun C; Lee KY
J Cell Biochem; 2014 Oct; 115(10):1808-15. PubMed ID: 24905700
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
10. Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2.
Fan X; Rahnert JA; Murphy TC; Nanes MS; Greenfield EM; Rubin J
J Cell Physiol; 2006 May; 207(2):454-60. PubMed ID: 16419041
[TBL] [Abstract][Full Text] [Related]
11. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
13. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
14. Hydrostatic pressures promote initial osteodifferentiation with ERK1/2 not p38 MAPK signaling involved.
Liu J; Zhao Z; Li J; Zou L; Shuler C; Zou Y; Huang X; Li M; Wang J
J Cell Biochem; 2009 May; 107(2):224-32. PubMed ID: 19259952
[TBL] [Abstract][Full Text] [Related]
15. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
16. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2.
Lou J; Tu Y; Li S; Manske PR
Biochem Biophys Res Commun; 2000 Feb; 268(3):757-62. PubMed ID: 10679278
[TBL] [Abstract][Full Text] [Related]
17. PIASxbeta is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts.
Ali MM; Yoshizawa T; Ishibashi O; Matsuda A; Ikegame M; Shimomura J; Mera H; Nakashima K; Kawashima H
J Cell Sci; 2007 Aug; 120(Pt 15):2565-73. PubMed ID: 17623776
[TBL] [Abstract][Full Text] [Related]
18. Src enhances osteogenic differentiation through phosphorylation of Osterix.
Choi YH; Han Y; Lee SH; Cheong H; Chun KH; Yeo CY; Lee KY
Mol Cell Endocrinol; 2015 May; 407():85-97. PubMed ID: 25802190
[TBL] [Abstract][Full Text] [Related]
19. Activation of ERK mitogen-activated protein kinase in human cells by the mycotoxin patulin.
Wu TS; Yu FY; Su CC; Kan JC; Chung CP; Liu BH
Toxicol Appl Pharmacol; 2005 Sep; 207(2):103-11. PubMed ID: 16102563
[TBL] [Abstract][Full Text] [Related]
20. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway.
Hsu YL; Kuo PL
J Bone Miner Res; 2008 Jun; 23(6):949-60. PubMed ID: 18269307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
